This new position paper describes and analyses the current and potential applications and value creation of Generative AI for pharmaceutical companies.
News
The French Voluntary Trade Organization (VTO) market is consolidating, making VTOs increasingly important partners for pharma companies...
« High-performance Market Access Brand Plans require method, rigor and pragmatism » Our new publication on how to build...
This new paper highlights our analyses on: